Episódios
-
Stocks bouncing back after a rough week, as investors digest encouraging inflation data, as well as dovish rate commentary from Chicago Fed President Austan Goolsbee. So could a Santa Claus rally still be in the cards? Plus 2024 nearing an end, and it’s been a big year for stocks. And our traders are picking out the one chart that blew them away.
Fast Money Disclaimer
-
Two big risks facing the market, as rates and the dollar both continue to climb. What the rise means for equities, and where the 10-year yield is heading from here. Plus A slew of health care headlines impact the space. The pressure on insurers, a weight-loss shortage update, and the disappointing study results pushing one pharma stock lower.
Fast Money Disclaimer
-
Estão a faltar episódios?
-
Stocks selling off after the Federal Reserve slashed interest rates by a quarter point. Why Powell is indicating less rate cuts in 2025… and what it means for markets. Plus the momentum trades losing a ton of steam late in the day. What it all means for stocks into year-end.
Fast Money Disclaimer
-
Could the 10-year yield climb as high as 6%? The bold rate call out of one Wall Street firm, and what it would mean for this year’s rally. Plus A new funding round from one of the most valuable private companies, and what the CEO says could be next for the AI startup.
Fast Money Disclaimer
-
Bitcoin hitting another record high, as MicroStrategy jumps on news it will be added to the Nasdaq 100. Why the CEO is calling the crypto a “cyber Manhattan”, and the price tag he’s putting on Bitcoin. Plus Markets hovering near record highs, and Wall Street expectations are for another solid year. But could the new year ring in a 10% sell off? How one market strategist is forecasting 2025.
Fast Money Disclaimer
-
A rough prognosis for the health care sector, as new reports about RFK Jr’s allies point to a major overhang for vaccine makers. How names like Pfizer, Morderna, and Sanofi will fare under the new administration, as the entire health space comes into focus. Plus One more rate decision before the new year… and with expectations of another cut, could the Fed’s easing cycle be nearing an end? How next week’s rate decision will impact markets going into year end.
Fast Money Disclaimer
-
Another record close for Apple as the tech titan’s rally continues. The driving factors behind those gains, as the company’s market cap nears the $4 trillion mark. Plus Make Crypto Great Again? President-Elect Donald Trump weighing in on the crypto space as Bitcoin hovers near $100K. The future of crypto under Trump, and why the founder of the world’s first institutional Bitcoin fund says the rally is just getting started.
Fast Money Disclaimer
-
The Nasdaq reaching new heights, as the index surpasses 20,000 for the first time ever. The tech surge that brought it there, and if the rally has more room to run. Plus Nuclear energy taking off, as power hungry AI data centers drive fuel demand. An inside look at one uranium mine in Canada that’s 1600 feet underground.
Fast Money Disclaimer
-
Shares of Alphabet surging as Google unveils a ‘breakthrough’ quantum computing chip. What it means for the future of coding, and the areas of tech that could benefit. Plus A spotlight on the health insurance space, as the suspect in the UNH CEO murder investigation heads to his first court appearance. The latest details on his motives, and how it could all impact other players in the health insurance space.
Fast Money Disclaimer
-
Some of this year’s hottest stocks staging a major reversal to start the week. The Tech, restaurants, and asset manager stocks in the red, and if there’s more pain to come. Plus Major developments in the UnitedHealthcare CEO’s murder investigation, and the slaying has the whole insurance space under a spotlight. How AI may be behind a slew of claim denials… and what it means for the future of the industry.
Fast Money Disclaimer
-
Social stocks gaining momentum as an appeals court upholds the law requiring a ban or sale of TikTok. What it means for the likes of Meta and Snap… and when the social media platform could get blocked. Plus UNH notches its worst week since before the pandemic. The fallout from the company’s CEO’s murder… and how the company will move forward from here.
Fast Money Disclaimer
-
All eyes on tomorrow’s November jobs report, as stocks take a breather from their recent rally. The pockets of strength in today’s trading, and what tomorrow’s employment data could mean for the markets next move. Plus Bitcion finally breaking through the elusive $100,000 level. What the milestone means for the crypto space, and where retail investors are putting their money to work.
Fast Money Disclaimer
-
Big tech taking the lead, and driving the S&P 500 and Nasdaq to fresh record highs. How semis, software, and other sections of the tech trade can fuel your portfolio. Plus Fast Money’s Obesity Week coverage continues. Eli Lilly’s Chief Scientific Officer breaks down how the company’s obesity drug Zepbound performed in its first head-to-head clinical trial against Novo’s Wegovy, and what the results could mean for the weight loss drug wars.
Fast Money Disclaimer
-
Tariff threats and trade restrictions are the latest irritations in rising U.S/China tensions. But the Chartmaster Carter Worth says now could be the time to get in. What he’s seeing in the technicals, and how your money can fare in the China trade. Plus Fast Money’s special coverage of the weight loss drug space continues. How one biotech company is standing out from the competition, and how its obesity drug could do more than trim your waistline.
Fast Money Disclaimer
-
Intel CEO Pat Gelsinger stepping down, as the chipmaker looks to bounce back from a tumultuous couple of years. What the turnaround plans may look like now, and how Intel can keep up with competition. Plus Fast Money’s Obesity Week kicks off. The emerging players in the weight-loss drug battle, and what industry leaders see next for the space.
Fast Money Disclaimer
-
A check on the health of the consumer, as buyers gear up for Black Friday shopping. How gas prices, inflation, and mortgage rates are helping paint the picture for what to expect out of retailers this season. And will stocks keep powering higher into year end? The bullish case for equities to keep charging, and where there’s still opportunity in the market.
Fast Money Disclaimer
-
Listen to our traders take you behind the money...how to play the volatility...pops and drops and the movers you missed.
Fast Money Disclaimer
-
Retailers making some major moves as holiday shopping kicks into high gear. So after a volatile 2024, can the group end the year in good spirits? Plus Health care, Biotech, and Pharma all in focus as investors digest President-Elect Donald Trump’s FDA chief pick. How the new chief will impact those spaces, and the weight-loss drug race.
Fast Money Disclaimer -
Two tales of Tech playing out, as software and semi stocks diverge in the second half. The names leading the rip and dip, and if the trend will continue into year end. Plus How retail will fare this holiday season. Record holiday spending expected this year, as companies up their credit card interest. How it will all shake out ahead of the holidays.
Fast Money Disclaimer
- Mostrar mais
